Novo-rival opjusterer: Diabetesmidler præsterer godt

Novo Nordisks store amerikanske konkurrent Eli Lilly er kommet stærkere end ventet ud af tredje kvartal, hvor en stribe af selskabets vigtigste diabetesmidler overraskede positivt. Eli …

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

You must be logged in to post a comment.

Powered by WordPress | Designed by: Premium Themes | Thanks to Free WordPress 4 Themes, Download Premium WordPress Themes and
%d bloggers like this: